Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views - PubMed (original) (raw)
Review
. 2007 Nov;25(11):2896-902.
doi: 10.1634/stemcells.2007-0637. Epub 2007 Sep 27.
Affiliations
- PMID: 17901396
- DOI: 10.1634/stemcells.2007-0637
Review
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views
Donald G Phinney et al. Stem Cells. 2007 Nov.
Abstract
Mesenchymal stem cells or multipotent stromal cells (MSCs) isolated from the bone marrow of adult organisms were initially characterized as plastic adherent, fibroblastoid cells with the capacity to generate heterotopic osseous tissue when transplanted in vivo. In recent years, MSCs or MSC-like cells have been shown to reside within the connective tissue of most organs, and their surface phenotype has been well described. A large number of reports have also indicated that the cells possess the capacity to transdifferentiate into epithelial cells and lineages derived from the neuroectoderm. The broad developmental plasticity of MSCs was originally thought to contribute to their demonstrated efficacy in a wide variety of experimental animal models of disease as well as in human clinical trials. However, new findings suggest that the ability of MSCs to alter the tissue microenvironment via secretion of soluble factors may contribute more significantly than their capacity for transdifferentiation in tissue repair. Herein, we critically evaluate the literature describing the plasticity of MSCs and offer insight into how the molecular and functional heterogeneity of this cell population, which reflects the complexity of marrow stroma as an organ system, may confound interpretation of their transdifferentiation potential. Additionally, we argue that this heterogeneity also provides a basis for the broad therapeutic efficacy of MSCs.
Similar articles
- Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. Psaltis PJ, et al. Stem Cells. 2008 Sep;26(9):2201-10. doi: 10.1634/stemcells.2008-0428. Epub 2008 Jul 3. Stem Cells. 2008. PMID: 18599808 Review. - Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.
Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ, Ott HC, Jauch KW, Bruns CJ. Conrad C, et al. Circulation. 2009 Jan 20;119(2):281-9. doi: 10.1161/CIRCULATIONAHA.108.793208. Epub 2008 Dec 31. Circulation. 2009. PMID: 19118255 - Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible.
Barzilay R, Melamed E, Offen D. Barzilay R, et al. Stem Cells. 2009 Oct;27(10):2509-15. doi: 10.1002/stem.172. Stem Cells. 2009. PMID: 19591229 Review. - The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair.
Arthur A, Zannettino A, Gronthos S. Arthur A, et al. J Cell Physiol. 2009 Feb;218(2):237-45. doi: 10.1002/jcp.21592. J Cell Physiol. 2009. PMID: 18792913 Review. - Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation.
Gregory CA, Prockop DJ, Spees JL. Gregory CA, et al. Exp Cell Res. 2005 Jun 10;306(2):330-5. doi: 10.1016/j.yexcr.2005.03.018. Epub 2005 Apr 15. Exp Cell Res. 2005. PMID: 15925588 Review.
Cited by
- Construction and Evaluation of Hepatic Targeted Drug Delivery System with Hydroxycamptothecin in Stem Cell-Derived Exosomes.
Zhao Q, Mo Z, Zeng L, Yuan Y, Wang Y, Wang Y. Zhao Q, et al. Molecules. 2024 Oct 31;29(21):5174. doi: 10.3390/molecules29215174. Molecules. 2024. PMID: 39519815 Free PMC article. - Molecular and Cellular Mechanisms of the Therapeutic Effect of Mesenchymal Stem Cells and Extracellular Vesicles in Corneal Regeneration.
Kobal N, Marzidovšek M, Schollmayer P, Maličev E, Hawlina M, Marzidovšek ZL. Kobal N, et al. Int J Mol Sci. 2024 Oct 16;25(20):11121. doi: 10.3390/ijms252011121. Int J Mol Sci. 2024. PMID: 39456906 Free PMC article. Review. - Application of Mesenchymal Stem Cells in Female Infertility Treatment: Protocols and Preliminary Results.
Chatzianagnosti S, Dermitzakis I, Theotokis P, Kousta E, Mastorakos G, Manthou ME. Chatzianagnosti S, et al. Life (Basel). 2024 Sep 13;14(9):1161. doi: 10.3390/life14091161. Life (Basel). 2024. PMID: 39337944 Free PMC article. Review. - Exosome-shuttled miR-150-5p from LPS-preconditioned mesenchymal stem cells down-regulate PI3K/Akt/mTOR pathway via Irs1 to enhance M2 macrophage polarization and confer protection against sepsis.
Zheng T, Li S, Zhang T, Fu W, Liu S, He Y, Wang X, Ma T. Zheng T, et al. Front Immunol. 2024 Jun 18;15:1397722. doi: 10.3389/fimmu.2024.1397722. eCollection 2024. Front Immunol. 2024. PMID: 38957471 Free PMC article. - Therapeutic potential of dedifferentiated fat cells in a rat model of osteoarthritis of the knee.
Endo N, Matsumoto T, Kazama T, Kano K, Shimizu M, Ryu K, Tokuhashi Y, Nakanishi K. Endo N, et al. Regen Ther. 2024 May 22;26:50-59. doi: 10.1016/j.reth.2024.05.006. eCollection 2024 Jun. Regen Ther. 2024. PMID: 38859891 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources